Vanderbilt Institute for Clinical and Translational Research (VICTR) Archive — Page 3 of 7
-
April 19, 2021
VUMC aids national effort to repurpose drugs for COVID-19
Vanderbilt University Medical Center (VUMC) has been named Data Coordinating Center (DCC) for a nationwide platform of studies aimed at “repurposing” existing drugs to treat mild to moderate symptoms of COVID-19. -
April 1, 2021
Study outlines VUMC’s strategy for a learning health care system
New investments in clinical programs at Vanderbilt University Medical Center are increasingly contingent upon studies to validate claims of benefit and the potential for scalability and spread. -
March 2, 2021
Study to evaluate effectiveness of COVID-19 vaccines in preventing hospitalization
As the Federal Drug Administration (FDA) considers adding a third COVID-19 vaccine to the rollout, a multicenter study led by Vanderbilt University Medical Center will evaluate how effective the vaccines are in preventing hospitalization from COVID-19. -
October 29, 2020
Self named VP for Clinical Research Networks and Strategy
Wesley Self, MD, MPH, has been appointed Vice President for Clinical Research Networks and Strategy at Vanderbilt University Medical Center. -
July 30, 2020
Hartmann named first Vice President for Research Integration
Katherine Hartmann, MD, PhD, Associate Dean for Clinical and Translational Scientist Development, has been named Vice President for Research Integration for Vanderbilt University Medical Center. -
July 23, 2020
Rice named to new leadership role for VICTR operations
Todd Rice, MD, MSc, has been appointed vice president for Clinical Trial Innovation and Operations in the Vanderbilt Institute for Clinical and Translational Research (VICTR). -
July 10, 2020
VUMC team fills COVID information gaps for web users
For the world’s web users, Vanderbilt University Medical Center is working with Google to address COVID-19 information gaps.